| GPCRdb in 2018: adding GPCR structure models and ligands G Pándy-Szekeres, C Munk, TM Tsonkov, S Mordalski, K Harpsøe, ... Nucleic acids research 46 (D1), D440-D446, 2018 | 516 | 2018 |
| GPCRdb: an information system for G protein-coupled receptors V Isberg, S Mordalski, C Munk, K Rataj, K Harpsøe, AS Hauser, B Vroling, ... Nucleic acids research 44 (D1), D356-D364, 2016 | 321 | 2016 |
| GPCRdb: the G protein‐coupled receptor database–an introduction C Munk, V Isberg, S Mordalski, K Harpsøe, K Rataj, AS Hauser, P Kolb, ... British Journal of Pharmacology 173 (14), 2195-2207, 2016 | 222 | 2016 |
| Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2-and 3-substituted 1, 2, 3, 4-tetrahydro-beta-carbolines. AJ Bojarski, MT Cegła, S Charakchieva-Minol, MJ Mokrosz, M Maćkowiak, ... Die Pharmazie 48 (4), 289-294, 1993 | 135 | 1993 |
| Homology Modeling of the Serotonin 5-HT1A Receptor Using Automated Docking of Bioactive Compounds with Defined Geometry M Nowak, M Kołaczkowski, M Pawłowski, AJ Bojarski Journal of medicinal chemistry 49 (1), 205-214, 2006 | 114 | 2006 |
| Functional selectivity and antidepressant activity of serotonin 1A receptor ligands Z Chilmonczyk, AJ Bojarski, A Pilc, I Sylte International journal of molecular sciences 16 (8), 18474-18506, 2015 | 105 | 2015 |
| Synthesis of 4‐substituted 2‐(4‐methylpiperazino)pyrimidines and quinazoline analogs as serotonin 5‐HT2A receptor ligands J Saczewski, A Paluchowska, J Klenc, E Raux, S Barnes, S Sullivan, ... Journal of Heterocyclic Chemistry 46 (6), 1259-1265, 2009 | 102 | 2009 |
| Synthesis of New Arylpiperazinylalkylthiobenzimidazole, Benzothiazole, or Benzoxazole Derivatives as Potent and Selective 5-HT1A Serotonin Receptor Ligands MA Siracusa, L Salerno, MN Modica, V Pittalà, G Romeo, ME Amato, ... Journal of medicinal chemistry 51 (15), 4529-4538, 2008 | 100 | 2008 |
| Receptor-Based Pharmacophores for Serotonin 5-HT7R AntagonistsImplications to Selectivity M Kołaczkowski, M Nowak, M Pawłowski, AJ Bojarski Journal of medicinal chemistry 49 (23), 6732-6741, 2006 | 96 | 2006 |
| Antidepressant and antipsychotic activity of new quinoline-and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors P Zajdel, K Marciniec, A Maślankiewicz, K Grychowska, G Satała, ... European Journal of Medicinal Chemistry 60, 42-50, 2013 | 94 | 2013 |
| Quinoline-and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents? P Zajdel, A Partyka, K Marciniec, AJ Bojarski, M Pawlowski, ... Future medicinal chemistry 6 (1), 57-75, 2014 | 85 | 2014 |
| The influence of negative training set size on machine learning-based virtual screening R Kurczab, S Smusz, AJ Bojarski Journal of cheminformatics 6, 1-9, 2014 | 80 | 2014 |
| Robust optimization of SVM hyperparameters in the classification of bioactive compounds WM Czarnecki, S Podlewska, AJ Bojarski Journal of cheminformatics 7, 1-15, 2015 | 75 | 2015 |
| Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with … K Grychowska, G Satała, T Kos, A Partyka, E Colacino, ... ACS Chemical Neuroscience 7 (7), 972-983, 2016 | 72 | 2016 |
| Protective effect of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of … L Antkiewicz-Michaluk, J Wardas, J Michaluk, I Romańska, A Bojarski, ... International Journal of Neuropsychopharmacology 7 (2), 155-163, 2004 | 71 | 2004 |
| Salt bridge in ligand–protein complexes—systematic theoretical and statistical investigations R Kurczab, P Śliwa, K Rataj, R Kafel, AJ Bojarski Journal of Chemical Information and Modeling 58 (11), 2224-2238, 2018 | 67 | 2018 |
| Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides L Strekowski, M Say, M Henary, P Ruiz, L Manzel, DE Macfarlane, ... Journal of medicinal chemistry 46 (7), 1242-1249, 2003 | 66 | 2003 |
| 1-Methyl-1, 2, 3, 4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain L Antkiewicz-Michaluk, B Karolewicz, I Romańska, J Michaluk, AJ Bojarski, ... European journal of pharmacology 466 (3), 263-269, 2003 | 64 | 2003 |
| Quinoline-and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation P Zajdel, K Marciniec, A Maślankiewicz, G Satała, B Duszyńska, ... Bioorganic & medicinal chemistry 20 (4), 1545-1556, 2012 | 63 | 2012 |
| Aminergic gpcr–ligand interactions: A chemical and structural map of receptor mutation data M Vass, S Podlewska, IJP De Esch, AJ Bojarski, R Leurs, AJ Kooistra, ... Journal of medicinal chemistry 62 (8), 3784-3839, 2018 | 58 | 2018 |
Rafał KurczabMaj Institute of Pharmacology PASVahvistettu sähköpostiosoite verkkotunnuksessa if-pan.krakow.pl
